Evidence map›Paper›PMID 16424445›Full record

ArticleAmerican journal of respiratory and critical care medicine2006

Calcineurin regulates myocardial function during acute endotoxemia.

Mandar S Joshi, Mark W Julian, Jennifer E Huff, John A Bauer, Yong Xia, Elliott D Crouser

Abstract read
In one paragraph

Article in American journal of respiratory and critical care medicine, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 67 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Exogenous HContrast media & molecular imaging · 2022
    Article
  7. Cardiovascular effects of immunosuppression agents.Frontiers in cardiovascular medicine · 2022
    Review
  8. An Overview on Mitochondrial-Based Therapies in Sepsis-Related Myocardial Dysfunction: Mitochondrial Transplantation as a Promising Approach.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2022
    Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Involvement of Mitochondrial Disorders in Septic Cardiomyopathy.Oxidative medicine and cellular longevity · 2017
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Mandar S JoshiCenter for Cardiovascular Medicine, Columbus Children's Research Institute, Ohio State University Medical Center, Columbus, OH 43210-1252, USA.
Mark W Julian
Jennifer E Huff
John A Bauer
Yong Xia
Elliott D Crouser
The Ohio State University Wexner Medical Center · US

Funding

COCAINE AND CARDIOVASCULAR DYSFUNCTION IN MURINE AIDSR01HL063067 · NHLBI · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI BAUER, JOHN ANTHONY · 1999 to 2003
$1.2M
MITOCHONDRIAL CYTOCHROME C RELEASE VIA MEMBRANE PORESK08HL004335 · NHLBI · OHIO STATE UNIVERSITY · PI CROUSER, ELLIOTT D · 2000 to 2004
$633k
CARDIOVASCULAR DYSFUNCTION AND NO CONTROL IN MURINE AIDSR01HL059791 · NHLBI · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI BAUER, JOHN ANTHONY · 1997 to 2001
$284k
NHLBI NIH HHS HL04335NHLBI NIH HHS HL59791NHLBI NIH HHS HL63067
6 · The paper itself

Abstract

rationaleCyclosporin A (CsA) is known to preserve cardiac contractile function during endotoxemia, but the mechanism is unclear. Increased nitric oxide (NO) production and altered mitochondrial function are implicated as mechanisms contributing to sepsis-induced cardiac dysfunction, and CsA has the capacity to reduce NO production and inhibit mitochondrial dysfunction relating to the mitochondrial permeability transition (MPT).

objectivesWe hypothesized that CsA would protect against endotoxin-mediated cardiac contractile dysfunction by attenuating NO production and preserving mitochondrial function.

methodsLeft ventricular function was measured continuously over 4 h in cats assigned as follows: control animals (n = 7); LPS alone (3 mg/kg, n = 8); and CsA (6 mg/kg, n = 7), a calcineurin inhibitor that blocks the MPT, or tacrolimus (FK506, 0.1 mg/kg, n = 7), a calcineurin inhibitor lacking MPT activity, followed in 30 min by LPS. Myocardial tissue was then analyzed for NO synthase-2 expression, tissue nitration, protein carbonylation, and mitochondrial morphology and function. MEASUREMENTS AND MAIN

resultsLPS treatment resulted in impaired left ventricular contractility, altered mitochondrial morphology and function, and increased protein nitration. As hypothesized, CsA pretreatment normalized cardiac performance and mitochondrial respiration and reduced myocardial protein nitration. Unexpectedly, FK506 pretreatment had similar effects, normalizing both cardiac and mitochondrial parameters. However, CsA and FK506 pretreatments markedly increased protein carbonylation in the myocardium despite elevated manganese superoxide dismutase activity during endotoxemia.

conclusionsOur data indicate that calcineurin is a critical regulator of mitochondrial respiration, tissue nitration, protein carbonylation, and contractile function in the heart during acute endotoxemia.

Indexed as

Calcineurin InhibitorsAnimalsCatsCyclosporineEndotoxemiaMitochondria, HeartMitochondrial Membrane Transport ProteinsMitochondrial Permeability Transition PoreMyocardial ContractionMyocardiumNitric Oxide Synthase Type IIPeroxidaseProtein CarbonylationSuperoxide DismutaseTacrolimusTyrosine3-nitrotyrosineCalcineurin InhibitorsCyclosporineMitochondrial Membrane Transport ProteinsMitochondrial Permeability Transition PoreNitric Oxide Synthase Type IIPeroxidaseSuperoxide DismutaseTacrolimusTyrosine

Identifiers

PMID16424445
PMCPMC2662919
OpenAlexW2152746794

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.